Simon M
Senior Member (Voting Rights)
A new research landscape emerges in America
Things are changing in the US for ME/CFS research as four new collaboratives set up and get to work.
In September last year, the National Institutes of Health (NIH) announced $35 million of funding to establish three new ME/CFS research collaboratives and a supporting Data Management Coordinating Centre. Since then, the Open Medicine Foundation (OMF) has said it plans to invest $5 million to fund a fourth research collaborative, at Stanford.
So that's four new collaboratives based at leading institutions, using top researchers and clinicians and backed by a substantial amount of cash. The collaboratives will be using cutting-edge technology and large, well-defined samples of patients. This adds up to a game-changer for biomedical research in the US, setting it way ahead of the rest of the world.
The NIH-funded collaboratives are:
Each NIH-funded collaborative has been awarded around $10 million each over five years, with around $5 million for the data centre.
NIH director Dr Francis Collins said the collaboratives would "lead to knowledge about the causes and ways to treat people affected by this mysterious, heart-breaking, and debilitating disease". All the collaboratives have said they aim to understand the mechanisms of the illness in order to develop treatments and to identify biomarkers.
The four collaboratives

...
Read the full blog at ME/CFS Research Review
Things are changing in the US for ME/CFS research as four new collaboratives set up and get to work.
In September last year, the National Institutes of Health (NIH) announced $35 million of funding to establish three new ME/CFS research collaboratives and a supporting Data Management Coordinating Centre. Since then, the Open Medicine Foundation (OMF) has said it plans to invest $5 million to fund a fourth research collaborative, at Stanford.
So that's four new collaboratives based at leading institutions, using top researchers and clinicians and backed by a substantial amount of cash. The collaboratives will be using cutting-edge technology and large, well-defined samples of patients. This adds up to a game-changer for biomedical research in the US, setting it way ahead of the rest of the world.
The NIH-funded collaboratives are:
- The Center for Solutions for ME/CFS headed up by Dr Ian Lipkin and based at Columbia University in New York City.
- The Cornell ME/CFS Collaborative Research Center led by Dr Maureen Hanson at Ithaca, New York State.
- The Jackson Laboratory ME/CFS Collaborative Research Center led by Dr Derya Unutmatz and based in Connecticut.
Each NIH-funded collaborative has been awarded around $10 million each over five years, with around $5 million for the data centre.
NIH director Dr Francis Collins said the collaboratives would "lead to knowledge about the causes and ways to treat people affected by this mysterious, heart-breaking, and debilitating disease". All the collaboratives have said they aim to understand the mechanisms of the illness in order to develop treatments and to identify biomarkers.
- The ME/CFS research collaborative at Stanford will be run by Dr Ron Davis and funded by OMF through donations it receives from patients and supporters.
The four collaboratives

...
Read the full blog at ME/CFS Research Review
Last edited: